SARA SCHUTT: Open Payments
NPI 1528661246 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 15 payments from 11 companies in 2025. Trend: 2023 $226 · 2024 $142 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $171 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| ABBVIE INC. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| SERVIER PHARMACEUTICALS LLC | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Genmab U.S., Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
Products named: RYBREVANT, Epkinly, PLUVICTO, LYNOZYFIC, Nubeqa, Tibsovo, ZENPEP, Enhertu.
Industry payments across NE — which companies pay providers there.
